Houston, Texas (PRWEB) December 20, 2012
The National Eagles and Angels Association (NEAA) held its past meeting in Dallas, Texas. InterlinkedTV has exclusive coverage of the interviews of companies that presented at that event.
Drew Diaz, CEO of Heart Test Laboratories, Inc. granted an Exclusive Interview for Interlinked and InterlinkedTV during the last National Eagles and Angles Association (NEAA) Meeting during which he discussed the company’s early Heart Disease detection capability. In the interview, Drew Diaz explains how heart disease affects people of all ages, and that their product is helping doctors diagnose heart disease early to prevent heart attacks.
"A lot of people are walking around that look good and feel good, asymptomatic. They go visit their doctor, they are told by their doctor that they can go home because they just had an ECG test or physical and they have a heart attack 6 months later. This technology is really geared for the front-side of medicine; for those doctors that are seeing all these patients every day for their annual physical and their checkups." Diaz said "Everywhere where there is an ECG device, there should be a MyoVista device to properly screen both young and older patients."
Heart Test Laboratories Inc.'s patent pending product will replace the 100 year old ECG that is prevalent in all doctors’ offices. The market for their product in 2012 is estimated to be $4 billion dollars.
"I remember getting a call from the hospital that my father had dropped at an airport at 55 from a heart attack. He had just had a checkup and his ECG (EKG) was perfect. I like so many other people wonder could this have been detected or prevented? I have been following Drew Diaz and this company for over 3 years now and b
Copyright©2012 Vocus, Inc.
All rights reserved